000 | 01967 a2200541 4500 | ||
---|---|---|---|
005 | 20250515034339.0 | ||
264 | 0 | _c20070112 | |
008 | 200701s 0 0 eng d | ||
022 | _a0001-5385 | ||
024 | 7 |
_a10.2143/AC.61.3.2014836 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaitland-van der Zee, Anke-Hilse | |
245 | 0 | 0 |
_aApolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS). _h[electronic resource] |
260 |
_bActa cardiologica _cJun 2006 |
||
300 |
_a327-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
650 | 0 | 4 |
_aApolipoprotein E2 _xgenetics |
650 | 0 | 4 |
_aApolipoprotein E3 _xgenetics |
650 | 0 | 4 |
_aApolipoprotein E4 _xgenetics |
650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
650 | 0 | 4 | _aGenetic Carrier Screening |
650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aStatistics as Topic |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aJukema, J Wouter | |
700 | 1 | _aZwinderman, Aeilko H | |
700 | 1 | _aHallman, D Michael | |
700 | 1 | _aDe Boer, Anthonius | |
700 | 1 | _aKastelein, John J P | |
700 | 1 | _aDe Knijff, Peter | |
773 | 0 |
_tActa cardiologica _gvol. 61 _gno. 3 _gp. 327-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2143/AC.61.3.2014836 _zAvailable from publisher's website |
999 |
_c16458741 _d16458741 |